Harbin Pharmaceutical Group Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 2,735

Employees

  • Stock Symbol
  • 600829

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $1.53
  • (As of Friday Closing)

Harbin Pharmaceutical Group General Information

Description

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Contact Information

Website
www.hayao.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Number 7, Qunli Avenue
  • Daoli District
  • Harbin, Heilongjiang 150070
  • China
+86 400
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Number 7, Qunli Avenue
  • Daoli District
  • Harbin, Heilongjiang 150070
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Harbin Pharmaceutical Group Stock Performance

As of 13-Nov-2026, Harbin Pharmaceutical Group’s stock price is $1.53. Its current market cap is $885M with 580M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.53 $1.47 $1.11 - $2.55 $885M 580M 20.1M $0.04

Harbin Pharmaceutical Group Financials Summary

As of 30-Sep-2026, Harbin Pharmaceutical Group has a trailing 12-month revenue of $1.54B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 816,863 912,159 616,266 654,684
Revenue 1,543,520 1,443,228 1,400,367 1,468,573
EBITDA 35,612 37,419 51,463 65,990
Net Income 23,008 18,611 29,722 41,296
Total Assets 1,105,534 1,025,466 981,655 1,047,663
Total Debt 104,749 104,674 123,306 143,778
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Harbin Pharmaceutical Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Harbin Pharmaceutical Group‘s full profile, request access.

Request a free trial

Harbin Pharmaceutical Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engag
Pharmaceuticals
Harbin, China
2,735 As of 2025

Hauppauge, NY

Hong Kong, Hong Kong
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Harbin Pharmaceutical Group Competitors (24)

One of Harbin Pharmaceutical Group’s 24 competitors is LNK International, a Corporation company based in Hauppauge, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LNK International Corporation Hauppauge, NY
China Resources Pharmaceutical Group Corporation Hong Kong, Hong Kong
Pfizer (Vienna) Corporation Vienna, Austria
OncBioMune Pharmaceuticals Corporate Backed or Acquired Baton Rouge, LA
Pfizer Pakistan Corporation Karachi, Pakistan
You’re viewing 5 of 24 competitors. Get the full list »

Harbin Pharmaceutical Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Harbin Pharmaceutical Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Harbin Pharmaceutical Group‘s full profile, request access.

Request a free trial

Harbin Pharmaceutical Group Investments & Acquisitions (4)

Harbin Pharmaceutical Group’s most recent deal was a Buyout/LBO with General Nutrition Centers for . The deal was made on 07-Aug-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
General Nutrition Centers 07-Aug-2020 Buyout/LBO Pharmaceuticals
Chinese Health Products (GNC/Harbin Pharmaceutical Group) 13-Feb-2019 Joint Venture Other Consumer Non-Durables
General Nutrition Centers 13-Feb-2019 PIPE Pharmaceuticals
Pfizer(swine vaccine business) 31-May-2010 Merger/Acquisition Drug Delivery
To view Harbin Pharmaceutical Group’s complete investments and acquisitions history, request access »

Harbin Pharmaceutical Group ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Harbin Pharmaceutical Group’s complete esg history, request access »

Harbin Pharmaceutical Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
General Nutrition Centers Pittsburgh, PA 1935

Harbin Pharmaceutical Group FAQs

  • When was Harbin Pharmaceutical Group founded?

    Harbin Pharmaceutical Group was founded in 1989.

  • Where is Harbin Pharmaceutical Group headquartered?

    Harbin Pharmaceutical Group is headquartered in Harbin, China.

  • What is the size of Harbin Pharmaceutical Group?

    Harbin Pharmaceutical Group has 2,735 total employees.

  • What industry is Harbin Pharmaceutical Group in?

    Harbin Pharmaceutical Group’s primary industry is Pharmaceuticals.

  • Is Harbin Pharmaceutical Group a private or public company?

    Harbin Pharmaceutical Group is a Public company.

  • What is Harbin Pharmaceutical Group’s stock symbol?

    The ticker symbol for Harbin Pharmaceutical Group is 600829.

  • What is the current stock price of Harbin Pharmaceutical Group?

    As of 13-Nov-2026 the stock price of Harbin Pharmaceutical Group is $1.53.

  • What is the current market cap of Harbin Pharmaceutical Group?

    The current market capitalization of Harbin Pharmaceutical Group is $885M.

  • What is Harbin Pharmaceutical Group’s current revenue?

    The trailing twelve month revenue for Harbin Pharmaceutical Group is $1.54B.

  • Who are Harbin Pharmaceutical Group’s competitors?

    LNK International, China Resources Pharmaceutical Group, Pfizer (Vienna), OncBioMune Pharmaceuticals, and Pfizer Pakistan are some of the 24 competitors of Harbin Pharmaceutical Group.

  • What is Harbin Pharmaceutical Group’s annual earnings per share (EPS)?

    Harbin Pharmaceutical Group’s EPS for 12 months was $0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process